Suppr超能文献

新型吲哚类磷酸二酯酶4(PDE4)抑制剂系列I的合成与生物学评价

The synthesis and biological evaluation of a novel series of indole PDE4 inhibitors I.

作者信息

Hulme C, Moriarty K, Miller B, Mathew R, Ramanjulu M, Cox P, Souness J, Page K M, Uhl J, Travis J, Huang F C, Labaudiniere R, Djuric S W

机构信息

Rhône-Poulenc Rorer Central Research, Collegeville, PA 19426, USA.

出版信息

Bioorg Med Chem Lett. 1998 Jul 21;8(14):1867-72. doi: 10.1016/s0960-894x(98)00324-2.

Abstract

This communication describes the synthesis and in vitro evaluation of a novel potent series of phosphodiesterase type (IV) (PDE4) inhibitors. The compounds described contain an indole moiety which replaces the 'rolipram-like' 3-methoxy-4-cyclopentoxy motif. Several of the compounds presented possess low nanomolar IC50's for PDEIV inhibition. In vivo activities determined from measurement of serum TNF-alpha levels in LPS challenged mice (mouse endotoxemia model) are also reported.

摘要

本通讯描述了一系列新型强效磷酸二酯酶IV(PDE4)抑制剂的合成及体外评价。所描述的化合物含有一个吲哚部分,其取代了“咯利普兰样”的3-甲氧基-4-环戊氧基基序。所展示的几种化合物对PDEIV抑制的IC50值低至纳摩尔级别。还报告了通过测量脂多糖攻击小鼠(小鼠内毒素血症模型)血清中TNF-α水平所确定的体内活性。

相似文献

2
Orally active indole N-oxide PDE4 inhibitors.口服活性吲哚N-氧化物磷酸二酯酶4抑制剂。
Bioorg Med Chem Lett. 1998 Nov 3;8(21):3053-8. doi: 10.1016/s0960-894x(98)00572-1.
3
Quaternary substituted PDE4 inhibitors I: the synthesis and in vitro evaluation of a novel series of oxindoles.
Bioorg Med Chem Lett. 1998 Jan 20;8(2):175-8. doi: 10.1016/s0960-894x(97)10206-2.
4
Aryl sulfonamides as selective PDE4 inhibitors.
Bioorg Med Chem Lett. 1998 Oct 6;8(19):2635-40. doi: 10.1016/s0960-894x(98)00491-0.
6
The synthesis and biological evaluation of a novel series of phthalazine PDE4 inhibitors I.
Bioorg Med Chem Lett. 2000 Oct 2;10(19):2235-8. doi: 10.1016/s0960-894x(00)00449-2.
7
7-Methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 inhibitors: a potential treatment for asthma.
Bioorg Med Chem Lett. 2002 Feb 11;12(3):509-12. doi: 10.1016/s0960-894x(01)00786-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验